Is margetuximab already on the market? What is its listing status and approval time?

Margetuximab is a monoclonal antibody drug used to treat HER2-positive breast cancer and has been approved in many countries. It kills cancer cells by specifically binding to the HER2 receptor, preventing the proliferation of cancer cells and activating the immune system. The drug offers a new treatment option in the treatment of HER2-positive breast cancer, especially in patients who have failed other treatments. Margetuximab is currently on the market in China, but due to its short time on the market, the relevant price has not yet been clarified, and it has not yet been included in medical insurance.

The original drug of margetuximab has been approved for marketing in the domestic market, but the specific price still needs to be confirmed based on the latest information provided by pharmacies and medical institutions in various places. Since this drug has not yet been included in China’s medical insurance, patients need to bear higher costs. The common specifications on the market are 250mg/10ml*1bottle/box, and the price may reach more than 30,000 yuan. Patients can learn the latest price information of drugs through the hospital pharmacy or related channels when purchasing.

In the international market, margetuximab has already been approved by many countries and regions. For example, in Europe and Japan, the original version of the drug has been launched and supplied, becoming an important drug for the treatment of HER2-positive breast cancer. The approval time of margetuximab varies slightly in different regions, but in general, the drug has been widely used in clinical applications since its launch, especially playing an important role in patients' treatment options.

Currently, there are no generic versions of margetuximab on the market. Because the drug is relatively new, it may take some time for generic versions to be produced and approved. Therefore, patients currently can only choose to use original drugs. Considering the high price, patients should consult medical institutions for the latest price information when purchasing drugs to ensure that they can get the most appropriate treatment plan.

Reference materials:https://www.margenza.com/